Caspases are
cysteine-aspartic
proteases that were initially discovered to play a role in apoptosis. However,
caspase 8, in particular, also has additional nonapoptotic roles, such as in
inflammation. Adipocyte cell death and
inflammation are hypothesized to be initiating pathogenic factors in
type 2 diabetes. Here, we examined the pleiotropic role of
caspase 8 in adipocytes and
obesity-associated
insulin resistance.
Caspase 8 expression was increased in adipocytes from mice and humans with
obesity and
insulin resistance. Treatment of 3T3-L1 adipocytes with
caspase 8 inhibitor
Z-IETD-FMK decreased both
death receptor-mediated signaling and targets of nuclear factor κ-light-chain-enhancer of activated B (NF-κB) signaling. We generated novel adipose tissue and adipocyte-specific
caspase 8 knockout mice (aP2Casp8-/- and adipoqCasp8-/-). Both males and females had improved
glucose tolerance in the setting of high-fat diet (HFD) feeding. Knockout mice also gained less weight on HFD, with decreased adiposity, adipocyte size, and hepatic steatosis. These mice had decreased adipose tissue
inflammation and decreased activation of canonical and noncanonical NF-κB signaling. Furthermore, they demonstrated increased energy expenditure, core body temperature, and UCP1 expression. Adipocyte-specific activation of
Ikbkb or housing mice at thermoneutrality attenuated improvements in
glucose tolerance. These data demonstrate an important role for
caspase 8 in mediating adipocyte cell death and
inflammation to regulate
glucose and energy homeostasis.
ARTICLE HIGHLIGHTS:
Caspase 8 is increased in adipocytes from mice and humans with
obesity and
insulin resistance. Knockdown of
caspase 8 in adipocytes protects mice from
glucose intolerance and
weight gain on a high-fat diet. Knockdown of
caspase 8 decreases Fas signaling, as well as canonical and noncanonical nuclear factor κ-light-chain-enhancer of activated B (NF-κB) signaling in adipose tissue. Improved
glucose tolerance occurs via reduced activation of NF-κB signaling and via induction of UCP1 in adipocytes.